Clinicopathological Implications of TIM3 Tumor-infiltrating Lymphocytes and the MiR-455-5p/Galectin-9 Axis in Skull Base Chordoma Patients
Overview
Oncology
Pharmacology
Authors
Affiliations
Chordoma is difficult to eradicate due to high local recurrence rates. The immune microenvironment is closely associated with tumor prognosis; however, its role in skull base chordoma is unknown. The expression of Galectin-9 (Gal9) and tumor-infiltrating lymphocyte (TIL) markers was assessed by immunohistochemistry. Kaplan-Meier and multivariate Cox analyses were used to assessing local recurrence-free survival (LRFS) and overall survival (OS) of patients. MiR-455-5p was identified as a regulator of Gal9 expression. Immunopositivity for Gal9 was associated with tumor invasion (p = 0.019), Karnofsky performance status (KPS) score (p = 0.017), and total TIL count (p < 0.001); downregulation of miR-455-5p was correlated with tumor invasion (p = 0.017) and poor prognosis; and the T-cell immunoglobulin and mucin-domain 3 (TIM3) TIL count was associated with chordoma invasion (p = 0.010) and KPS score (p = 0.037). Furthermore, multivariate analysis indicated that only TIM3 TIL density was an independent prognostic factor for LRFS (p = 0.010) and OS (p = 0.016). These results can be used to predict clinical outcome and provide a basis for immune therapy in skull base chordoma patients.
TIM proteins and microRNAs: distinct impact and promising interactions on transplantation immunity.
Tao J, Shen X, Qian H, Ding Q, Wang L Front Immunol. 2024; 15:1500228.
PMID: 39650660 PMC: 11621082. DOI: 10.3389/fimmu.2024.1500228.
Immune microenvironment and immunotherapy for chordoma.
Chen Y, Zhang H Front Oncol. 2024; 14:1374249.
PMID: 38983929 PMC: 11232415. DOI: 10.3389/fonc.2024.1374249.
Wei M, Zhou G, Chen L, Zhang Y, Ma W, Gao L J Cancer. 2024; 15(12):3857-3872.
PMID: 38911364 PMC: 11190780. DOI: 10.7150/jca.96365.
Campilan B, Schroeder C, Sagaityte E, Arditi J, Leary O, Ziya L Gokaslan Front Oncol. 2024; 14:1330254.
PMID: 38544830 PMC: 10965562. DOI: 10.3389/fonc.2024.1330254.
Ghosh P, Ghosh A Mol Biol Rep. 2024; 51(1):125.
PMID: 38236360 DOI: 10.1007/s11033-023-09017-9.